Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Other Routine +

Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review

Datametrex AI Advances Patent Monetization with Hilco Global, but Execution Risks and Dilution Weigh on Shareholder Value

By The Northwire Desk — AI Analysis Jun 01, 2026 · 08:00 DM · 0.04 Datametrex AI Limited
Executive Summary
  • Datametrex AI Limited’s subsidiary, Paymetrex, completed Hilco Global’s initial due diligence review of its patent portfolio.
  • The portfolio successfully qualified for advancement into a structured licensing initiative focused on SoftPOS and mobile payment technologies.
  • The company anticipates the broader licensing program may commence within approximately two months.
  • Management explicitly cautions that the initiative remains exploratory, with no assurance that licensing agreements, royalty arrangements, or commercial outcomes will materialize.
  • This announcement follows the April 2026 disclosure of the Hilco partnership and the March 2026 royalty-bearing license with AnywhereCommerce.
Material Impact
  • The announcement represents incremental procedural progress on a previously disclosed strategic partnership rather than a new, market-moving catalyst.
  • Completion of due diligence is a standard milestone in IP monetization and does not equate to revenue generation or contract execution.
  • Management’s explicit disclaimer regarding unguaranteed commercial outcomes reinforces the speculative nature of this revenue stream.
  • The stock has declined significantly from its November 2025 high, indicating the market has already priced in the partnership and subsequent developments.
  • The news is routine and positive in tone but lacks the materiality required to reverse the current downtrend or fundamentally alter the company’s financial trajectory.
DM · Price
Company Overview
  • Datametrex AI Limited operates across three primary verticals: healthcare services (Imagine Health Medical Clinics), AI-driven data centre infrastructure (Nutanix-based HCI solutions via Datametrex Korea), and payments technology IP licensing (Paymetrex).
  • The flagship project is the Paymetrex patent licensing program, which aims to monetize a portfolio of mobile payment and SoftPOS patents through structured licensing agreements and AI-driven analytics.
  • The company has pivoted from traditional IT services toward recurring revenue models, including long-term data centre contracts and royalty-bearing IP licenses.
  • Management emphasizes a "land and expand" strategy, targeting enterprise clients in South Korea and North America for infrastructure solutions while simultaneously pursuing global IP monetization.
Read the original news release →

More from Datametrex AI Limited

Jun 30, 2026 · 08:00

Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative

M&A / Property Jun 15, 2026 · 08:30

Small-cap tech pivot: $650k software contracts and patent licensing progress offset by persistent losses and a 70% stock drawdown.

Other Jun 03, 2026 · 08:00

Datametrex AI Secures $1.8M in Nutanix Contracts as Margin Compression and Cash Burn Weigh on Venture Stock

Other May 22, 2026 · 08:00

Datametrex AI Limited Operational Expansion Masks Revenue Recognition Lag and Dilution Concerns

Production / Operations Apr 24, 2026 · 08:00

Datametrex pivots to quantum encryption amid revenue stagnation and share dilution

Other Apr 09, 2026 · 07:30

“$6 M Five‑Year Contract Adds Predictable Recurring Revenue, Boosts Datametrex Outlook”

Other